EP 0848957 A1 19980624 - Fas LIGAND SOLUBILIZATION INHIBITOR
Title (en)
Fas LIGAND SOLUBILIZATION INHIBITOR
Title (de)
Fas Ligand Löslichkeitsinhibitor
Title (fr)
INHIBITEUR DE SOLUBILISATION DE LIGAND Fas
Publication
Application
Priority
- JP 9602492 W 19960904
- JP 25689795 A 19950908
- JP 31713695 A 19951109
Abstract (en)
A Fas ligand solubilization inhibitor which comprises, as the active ingredient, a compound of the generic formula (I) having a matrix metalloproteinase inhibitory activity or its pharmaceutically acceptable salt. The drug is useful in the prevention or treatment of diseases caused by solubilized Fas ligand, such as hepatitis, GVHD, AIDS, autoimmune diseases, etc. <CHEM>
IPC 1-7
A61K 45/00; A61K 31/165; A61K 31/47; A61K 31/55; C07D 487/04; C07C 239/18
IPC 8 full level
C07C 259/06 (2006.01); C07D 217/04 (2006.01); C07D 223/16 (2006.01); C07D 265/30 (2006.01); C07D 333/60 (2006.01); C07D 403/12 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP)
C07C 259/06 (2013.01); C07D 217/04 (2013.01); C07D 223/16 (2013.01); C07D 265/30 (2013.01); C07D 333/60 (2013.01); C07D 403/12 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07C 2602/10 (2017.04)
Citation (search report)
See references of WO 9709066A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
DOCDB simple family (application)
JP 9602492 W 19960904; EP 96929510 A 19960904